top of page
ABOUT OUR INVESTORS
LIfT’s existing investors include Jonathan Milner (Meltwind & Abcam), Kizoo Technology Ventures, Starbloom Capital and Downing Ventures.
We are interested in investors joining the syndicate who personally share our mission to develop a cure for all solid tumours, and who can make a positive contribution to the future direction of the company.
LIfT is currently completing its Series A funding round as we move into clinical trials. If you would like to find out more about investing in LIfT BioSciences, please contact us.
OUR PARTNERS AND SUPPORTERS INCLUDE
bottom of page